Advances in research and treatment of chronic lymphocytic leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and can vary from person to person. This is why a one-size-fits-all treatment approach is not optimal. Research advances in how we treat CLL are discussed by Dr. Anthea Peters, Hematologist at the Cross Cancer Institute in Edmonton, and Associate Professor, Department of Oncology, University of Alberta.